机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, 88 South Keyuan Road, Chengdu 610093, China.四川大学华西医院[2]Institute of Translational Medicine, Shanghai University, 99 Shangda Road, Shanghai 200444, China.[3]Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.[4]Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning 530021, China.[5]Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.[6]Department of Pharmacology and Chemical Biology, School of Medicine, Shanghai Jiao Tong University, 280 South Chongqing Road, Shanghai 200025, China.[7]Department of Medical Oncology and Cancer Institute, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.
This study is supported by the National Natural Science Foundation of China
81981340417 (to LS), 1.3.5 project for disciplines of excellence, West China
Hospital, Sichuan University ZYGD18011 (to HL), China Postdoctoral Science
Foundation 2021M692301 (to DPK), Postdoctoral Research Foundation of
Sichuan University 2022SCU12037 (to DPK).
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, 88 South Keyuan Road, Chengdu 610093, China.[2]Institute of Translational Medicine, Shanghai University, 99 Shangda Road, Shanghai 200444, China.
通讯作者:
推荐引用方式(GB/T 7714):
Kong Depei,Ye Chen,Zhang Chenxi,et al.Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer[J].JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH.2023,42(1):doi:10.1186/s13046-023-02610-7.
APA:
Kong Depei,Ye Chen,Zhang Chenxi,Sun Xiaochen,Wang Fubo...&Su Li.(2023).Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,42,(1)
MLA:
Kong Depei,et al."Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 42..1(2023)